AI assistant
Syngene International Limited Call Transcript 2020
61231_rns_2020-07-17_06d3166b-84e2-43ba-900d-f5b5fdb7f1c0.pdf
Call Transcript
Open in viewerOpens in your device viewer
Biocon SEZ, Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area, IV Phase, Jigani Link Road, Bengaluru 560 099, Karnataka, India T +91 80 6891 8000 F +91 80 6775 8808 CIN: L85110KA1993PLC01493 July 17, 2020 www.syngeneintl.com
| To, | To, |
|---|---|
| The Manager, | The Manager, |
| BSE Limited | National Stock Exchange of India Limited |
| Corporate Relationship Department | Corporate Communication Department |
| Dalal Street, Mumbai –400 001 | Bandra (EAST), Mumbai –400 051 |
| Scrip Code: 539268 | Scrip Symbol: SYNGENE |
Subject: Intimation of Conference Call for Analysts and Investors
Dear Sir/Madam,
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the intimation for conference call for analysts and investors to be held on Wednesday, July 22, 2020.
The above-mentioned information will also be available on website of the Company www.syngeneintl.com.
Request to kindly take this intimation on record.
Thanking You,
Yours faithfully,
For SYNGENE INTERNATIONAL LIMITED
____________ PRIYADARSH INI MAHAPATRA Digitally signed by PRIYADARSHINI MAHAPATRA Date: 2020.07.17 14:31:26 +05'30'
Priyadarshini Mahapatra Company Secretary and Compliance Officer
Syngene's Q1 FY2021 Results Conference Call
At 02:30 pm IST on 22nd July, 2020
The management team of Syngene International Limited ("Syngene") will organize a conference call for Analysts and Investors on Wednesday, 22nd July at 02:30 pm IST following the announcement of financial results for the quarter ended June 30, 2020.
The call will be initiated with a brief management discussion on the Q1 FY2021 performance followed by an interactive Question & Answer session. Mr. Jonathan Hunt - Syngene's Managing Director and Chief Executive Officer and other members of the senior management team will represent Syngene on the conference call.
Details of the conference call are as under:
| Date: | Wednesday, 22nd July 2020 |
|---|---|
| Time: | 02:30 pm to 03:30 pm IST |
| Dial-in Numbers* | |
| Primary Number | +91 22 6280 1279 / +91 22 7115 8180 |
| Local Access Number | +91 70 4567 1221: Available all over India(Accessible from all carriers.) |
| International Numbers | •USA – 18667462133 (Toll Free) /+13233868721 (Toll)•UK – 08081011573 (Toll Free) /+442034785524 (Toll)•Singapore – 8001012045 (Toll Free) /+6531575746 (Toll)•Hong Kong – 800964448 (Toll Free) /+85230186877 (Toll)•Australia – 1800053698 (Toll Free) |
| Pre-registration Facility(DiamondPass™ link) | Step 1: Pre-register here.You will receive a passcode and a pin for thecall on the registered email address.Step 2: Dial into the call on the Conference Call date, enter the passcode& pin as prompted. You will be directly connected to the call |
*When using dial-in numbers mentioned please do so 10 minutes prior to the conference schedule to ensure that you are connected to your call in time
| Replay Facility | Dial in numbers: +91 22 7194 5757 / +91 22 6663 5757 |
|---|---|
| Playback ID: 40395 | |
| The replay facility will be available from 22nd July 2020 till 1st August 2020 | |
| Conference Call Transcript | Will be available within 7 working days of the call on the corporatewebsite: www.syngeneintl.com |
About Syngene
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022), is an innovation-focused global discovery, development and manufacturing organisation providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Syngene's clientele includes world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife. Its innovative culture is driven by the passion of its 4,240 strong team of scientists who work with clients from around the world to solve their scientific problems, improve R&D productivity, speed up time to market and lower the cost of innovation. For more details, visit www.syngeneintl.com.
For further information, please contact:
Krishnan G Syngene International : +91 8068919807 :[email protected]
Disclaimer: Certain of the statements that may be made or discussed at the conference call may be forwardlooking statements and/or based on management's current expectations and beliefs concerning future developments and their potential effects upon Syngene and its associates. There can be no assurance that future developments affecting Syngene and its associates will be those anticipated by management. These forward-looking statements are not a guarantee of future performance and involve risks and uncertainties and there are important factors that could cause actual results to differ, possibly materially, from expectations reflected in such forward-looking statements. Syngene does not intend, and is under no obligation, to update any particular forward-looking statement made at the conference call.